2011
DOI: 10.1016/j.jval.2011.08.583
|View full text |Cite
|
Sign up to set email alerts
|

PHP32 Market Access Variation for Lifestyle Disease Drugs in Europe

Abstract: approach to costing and uptake among populations considered. CONCLUSIONS: Rx-to-OTC switches are a real opportunity to realise savings for budget holders and productivity gains for employers. More robust economic models are required to estimate the impact of the switches in Europe.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles